Skip to content

aTyr Pharma ATYR Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin-40,856.3%-11,957pp-28,899.6%-13,342pp-15,557.8%
Net margin-39,009.5%-11,766pp-27,243.8%-12,969pp-14,274.5%
Returns
Return on equity-107.8%-28.1pp-79.7%-17.5pp-62.2%-12.0pp-50.2%-2.2pp
Return on invested capital-109.2%-22.6pp-86.6%-18.0pp-68.6%-18.3pp-50.3%+4.0pp
Efficiency
Asset turnover0.0×0.0×
Liquidity
Current ratio5.3×-0.2×5.5×-0.8×6.3×+0.4×5.8×-13.1×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×0.0×0.2×+0.2×
Per Share
Book value per share$0.73-23.0%$0.94-44.2%$1.69-32.7%$2.51-56.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do aTyr Pharma's ratios come from?
Every ratio is computed from aTyr Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.